Induction of oxidative stress and apoptosis in myeloma cells by the aziridine-containing agent imexon

被引:79
作者
Dvorakova, K
Payne, CM
Tome, ME
Briehl, MM
McClure, T
Dorr, RT
机构
[1] Univ Arizona, Arizona Canc Ctr, Tucson, AZ 85724 USA
[2] Univ Arizona, Dept Pathol, Tucson, AZ 85724 USA
[3] Novartis Agr Discovery Inst, La Jolla, CA 92121 USA
关键词
imexon; cyanoaziridine; multiple myeloma; oxidative stress; apoptosis;
D O I
10.1016/S0006-2952(00)00380-4
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Imexon is an iminopyrrolidone derivative that has selective antitumor activity in multiple myeloma, The exact mechanism of imexon action is unknown. In human 8226 myeloma cells, the cytotoxicity of imexon was schedule-dependent, and long exposures (greater than or equal to 48 hr) to low concentrations of imexon were most effective at inducing cytotoxicity. Our data suggest that imexon does not affect DNA, but it can alkylate thiols by binding to the sulfhydryl group. We have also demonstrated by HPLC studies that in human 8226 myeloma cells, imexon depletes cellular stores of cysteine and glutathione. Oxidative stress in 8226 cells exposed to imexon was detected by immunohistochemical staining with a monoclonal antibody to 8-hydroxydeoxyguanosine (8-OHdG), followed by confocal microscopy. These images showed increased levels of 8-OHdG in the cytoplasm of cells treated with different concentrations of imexon at 8, 16, and 48 hr. Interestingly, 8-OHdG staining was not observed in the nuclei of imexon-treated cells, in contrast to the diffuse staining seen with t-butyl hydroperoxide. Myeloma cells exposed to imexon showed classic morphologic features of apoptosis upon electron microscopy, and increased levels of phosphatidylserine exposure, detected as Annexin-V binding, on the cell surface. To prevent depletion of thiols, 8226 myeloma cells exposed to imexon were treated with N-acetylcysteine (NAC). Simultaneous, as well as sequential, treatment with NAC before imexon exposure resulted in protection of myeloma cells against imexon-induced cytotoxicity. Conversely, the glutathione synthesis inhibitor buthionine sulfoximine increased imexon cytotoxicity. These data suggest that imexon perturbs cellular thiols and induces oxidative stress leading to apoptosis in human myeloma cells. (C) 2000 Elsevier Science Inc.
引用
收藏
页码:749 / 758
页数:10
相关论文
共 33 条
  • [1] [Anonymous], IMMUNE MODULATION CO
  • [2] PRECLINICAL PHARMACOKINETICS AND ANTITUMOR-ACTIVITY OF IMEXON
    DORR, RT
    LIDDIL, JD
    KLEIN, MK
    HERSH, EM
    [J]. INVESTIGATIONAL NEW DRUGS, 1995, 13 (02) : 113 - 116
  • [3] DORR RT, 1986, INVEST NEW DRUG, V4, P305
  • [4] FARISS MW, 1987, METHOD ENZYMOL, V143, P101
  • [5] ANALYSIS OF MRP MESSENGER-RNA IN MITOXANTRONE-SELECTED, MULTIDRUG-RESISTANT HUMAN TUMOR-CELLS
    FUTSCHER, BW
    ABBASZADEGAN, MR
    DOMANN, F
    DALTON, WS
    [J]. BIOCHEMICAL PHARMACOLOGY, 1994, 47 (09) : 1601 - 1606
  • [6] NATURE OF CELLS GENERATING HUMAN MYELOMA COLONIES INVITRO
    HAMBURGER, AW
    KIM, MB
    SALMON, SE
    [J]. JOURNAL OF CELLULAR PHYSIOLOGY, 1979, 98 (02) : 371 - 376
  • [7] HARRIS AW, 1973, J IMMUNOL, V110, P431
  • [8] ANTIPROLIFERATIVE AND ANTITUMOR-ACTIVITY OF THE 2-CYANOAZIRIDINE COMPOUND IMEXON ON TUMOR-CELL LINES AND FRESH TUMOR-CELLS INVITRO
    HERSH, EM
    GSCHWIND, CR
    TAYLOR, CW
    DORR, RT
    TAETLE, R
    SALMON, SE
    [J]. JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1992, 84 (16) : 1238 - 1244
  • [9] SUPPRESSION OF HUMAN LYMPHOMA DEVELOPMENT IN THE SEVERE COMBINED IMMUNE-DEFICIENT MOUSE BY IMEXON THERAPY
    HERSH, EM
    GROGAN, TM
    FUNK, CY
    TAYLOR, CW
    [J]. JOURNAL OF IMMUNOTHERAPY, 1993, 13 (02): : 77 - 83
  • [10] Mitochondrial permeability transition in apoptosis and necrosis
    Hirsch, T
    Susin, SA
    Marzo, I
    Marchetti, P
    Zamzami, N
    Kroemer, G
    [J]. CELL BIOLOGY AND TOXICOLOGY, 1998, 14 (02) : 141 - 145